Dell Faulkingham, SVP, CCO at Akebia Therapeutics, Inc. (AKBA), sold 13,184 shares at $2.17 ($28K) on 2022-03-01, disclosed to the SEC on 2022-03-02.
Open-market sale of $28k AKBA by SVP, CCO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.15 | 6,479 | $14K | 48.9% |
| 2 | $2.17 | 957 | $2K | 7.3% |
| 3 | $2.17 | 5,748 | $12K | 43.8% |
| Total | $2.16 avg | 13,184 | $28K | 100% |
| Filing → |
| AKBA | SELL | 2020-06-02 | $149K | — | Filing → |